Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma
Abstract Oncolytic viruses (OVs) emerge as a promising cancer immunotherapy. However, the temporal impact on tumor cells and the tumor microenvironment, and the nature of anti-tumor immunity post-therapy remain largely unclear. Here we report that CD4+ T cells are required for durable tumor control...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-55455-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571523462856704 |
|---|---|
| author | Jeffrey M. Grimes Sadashib Ghosh Shamza Manzoor Li X. Li Monica M. Moran Jennifer C. Clements Sherrie D. Alexander James M. Markert Jianmei W. Leavenworth |
| author_facet | Jeffrey M. Grimes Sadashib Ghosh Shamza Manzoor Li X. Li Monica M. Moran Jennifer C. Clements Sherrie D. Alexander James M. Markert Jianmei W. Leavenworth |
| author_sort | Jeffrey M. Grimes |
| collection | DOAJ |
| description | Abstract Oncolytic viruses (OVs) emerge as a promising cancer immunotherapy. However, the temporal impact on tumor cells and the tumor microenvironment, and the nature of anti-tumor immunity post-therapy remain largely unclear. Here we report that CD4+ T cells are required for durable tumor control in syngeneic murine models of glioblastoma multiforme after treatment with an oncolytic herpes simplex virus (oHSV) engineered to express IL-12. The upregulated MHCII on residual tumor cells facilitates programmed polyfunctional CD4+ T cells for tumor control and for recall responses. Mechanistically, the proper ratio of Bcl-6 to T-bet in CD4+ T cells navigates their enhanced anti-tumor capacity, and a reciprocal IL6ra-Bcl-6 regulatory axis in a memory CD4+ T-cell subset, which requires MHCII signals from reprogrammed tumor cells, tumor-infiltrating and resident myeloid cells, is necessary for the prolonged response. These findings uncover an OV-induced tumor/myeloid-CD4+ T-cell partnership, leading to long-term anti-tumor immune memory, and improved OV therapeutic efficacy. |
| format | Article |
| id | doaj-art-76b9f9f3d87b45ba817c4d35b287b0d3 |
| institution | Kabale University |
| issn | 2041-1723 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Nature Communications |
| spelling | doaj-art-76b9f9f3d87b45ba817c4d35b287b0d32025-02-02T12:32:14ZengNature PortfolioNature Communications2041-17232025-01-0116112010.1038/s41467-024-55455-9Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastomaJeffrey M. Grimes0Sadashib Ghosh1Shamza Manzoor2Li X. Li3Monica M. Moran4Jennifer C. Clements5Sherrie D. Alexander6James M. Markert7Jianmei W. Leavenworth8Department of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamDepartment of Neurosurgery, University of Alabama at BirminghamAbstract Oncolytic viruses (OVs) emerge as a promising cancer immunotherapy. However, the temporal impact on tumor cells and the tumor microenvironment, and the nature of anti-tumor immunity post-therapy remain largely unclear. Here we report that CD4+ T cells are required for durable tumor control in syngeneic murine models of glioblastoma multiforme after treatment with an oncolytic herpes simplex virus (oHSV) engineered to express IL-12. The upregulated MHCII on residual tumor cells facilitates programmed polyfunctional CD4+ T cells for tumor control and for recall responses. Mechanistically, the proper ratio of Bcl-6 to T-bet in CD4+ T cells navigates their enhanced anti-tumor capacity, and a reciprocal IL6ra-Bcl-6 regulatory axis in a memory CD4+ T-cell subset, which requires MHCII signals from reprogrammed tumor cells, tumor-infiltrating and resident myeloid cells, is necessary for the prolonged response. These findings uncover an OV-induced tumor/myeloid-CD4+ T-cell partnership, leading to long-term anti-tumor immune memory, and improved OV therapeutic efficacy.https://doi.org/10.1038/s41467-024-55455-9 |
| spellingShingle | Jeffrey M. Grimes Sadashib Ghosh Shamza Manzoor Li X. Li Monica M. Moran Jennifer C. Clements Sherrie D. Alexander James M. Markert Jianmei W. Leavenworth Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma Nature Communications |
| title | Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma |
| title_full | Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma |
| title_fullStr | Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma |
| title_full_unstemmed | Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma |
| title_short | Oncolytic reprogramming of tumor microenvironment shapes CD4 T-cell memory via the IL6ra-Bcl6 axis for targeted control of glioblastoma |
| title_sort | oncolytic reprogramming of tumor microenvironment shapes cd4 t cell memory via the il6ra bcl6 axis for targeted control of glioblastoma |
| url | https://doi.org/10.1038/s41467-024-55455-9 |
| work_keys_str_mv | AT jeffreymgrimes oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT sadashibghosh oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT shamzamanzoor oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT lixli oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT monicammoran oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT jennifercclements oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT sherriedalexander oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT jamesmmarkert oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma AT jianmeiwleavenworth oncolyticreprogrammingoftumormicroenvironmentshapescd4tcellmemoryviatheil6rabcl6axisfortargetedcontrolofglioblastoma |